# Amathus Therapeutics, Inc.: Research, Cambridge, United States

> Amathus Therapeutics, Inc.: Amathus Therapeutics, Inc. Based in Cambridge, United States. Founded 2016.

Source: https://millionrounds.com/startup/amathus-therapeutics-inc (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Amathus Therapeutics, Inc.

Amathus Therapeutics, Inc.

Email

Funding reported Last round: Series A

Research Cambridge, United States

Follow Amathus Therapeutics, Inc. and see its new rounds in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Famathus-therapeutics-inc)

Company summary

- **Founded:** 2016 10 years old
- **Team:** 3 1 to 10 people
- **Funding reported:** $16M in dollars
- **Last round:** Series A Mar 2019

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Amathus Therapeutics, Inc. has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Amathus Therapeutics, Inc.

Amathus Therapeutics, Inc.

is a biopharmaceutical company based in Cambridge, MA, that specializes in developing small-molecule therapeutics for genetically defined diseases, particularly neurodegenerative and renal disorders. Founded in 2016, the company focuses on creating innovative treatments for conditions such as Parkinson's Disease and Polycystic Kidney Disease. The company is recognized for its expertise in small molecule modulators of organelle-specific chaperones. Its proprietary technology platform allows for precise modulation of mitochondrial and endoplasmic reticulum chaperones, targeting cellular stress response pathways to restore essential cellular functions affected by disease. Amathus has formed a strategic partnership with Merck to advance its pipeline of mitochondrial-targeted candidates, with potential milestone payments exceeding $500 million per program.

## What company datasets say Amathus Therapeutics, Inc. raised

Funding, as reported

Reported in all **$16M** in dollars

Last round **Series A**

Last round size **$16M**

Last round date **Mar 2019**

## The company, in detail

What they build

Known for

digital solutions strategic consulting management consulting custom software solutions user experience information technology and services performance marketing business growth mobile-friendly design project management biotechnology research digital marketing digital transformation marketing & advertising information technology & services performance-driven strategies

Built with from their website

IoT Remote Canal Micro

- **Sector:** Research
- **Industry code:** NAICS 54151, SIC 8742
- **Region:** Massachusetts

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Amathus Therapeutics, Inc. in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)